Non-interventional open single arm, multicentre study to observe the use of Preotact [ALX-111] in patients with severe postmenopausal osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PROPOSE
- Sponsors Takeda Pharmaceuticals International GmbH
- 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
- 22 Sep 2008 Actual patient number (110) added as reported by ClinicalTrials.gov.
- 22 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.